Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-122 |
Sentence |
denotes |
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring. |
T1 |
0-122 |
Sentence |
denotes |
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring. |
T2 |
123-282 |
Sentence |
denotes |
The effects of SARS-CoV-2 infection on individuals with immune-mediated glomerulonephritis, who are often undergoing immunosuppressive treatments, are unknown. |
T2 |
123-282 |
Sentence |
denotes |
The effects of SARS-CoV-2 infection on individuals with immune-mediated glomerulonephritis, who are often undergoing immunosuppressive treatments, are unknown. |
T3 |
283-496 |
Sentence |
denotes |
Therefore, we created the International Registry of COVID infection in glomerulonephritis (IRoc-GN), and identified 40 patients with glomerulonephritis and COVID-19 followed in centers in North America and Europe. |
T3 |
283-496 |
Sentence |
denotes |
Therefore, we created the International Registry of COVID infection in glomerulonephritis (IRoc-GN), and identified 40 patients with glomerulonephritis and COVID-19 followed in centers in North America and Europe. |
T4 |
497-739 |
Sentence |
denotes |
Detailed information on glomerulonephritis diagnosis, kidney parameters, and baseline immunosuppression prior to infection were recorded, as well as clinical presentation, laboratory values, treatment, complications, and outcomes of COVID-19. |
T4 |
497-739 |
Sentence |
denotes |
Detailed information on glomerulonephritis diagnosis, kidney parameters, and baseline immunosuppression prior to infection were recorded, as well as clinical presentation, laboratory values, treatment, complications, and outcomes of COVID-19. |
T5 |
740-889 |
Sentence |
denotes |
This cohort was compared to 80 COVID-positive control cases from the general population without glomerulonephritis matched for the time of infection. |
T5 |
740-889 |
Sentence |
denotes |
This cohort was compared to 80 COVID-positive control cases from the general population without glomerulonephritis matched for the time of infection. |
T6 |
890-988 |
Sentence |
denotes |
The majority (70%) of the patients with glomerulonephritis and all the controls were hospitalized. |
T6 |
890-988 |
Sentence |
denotes |
The majority (70%) of the patients with glomerulonephritis and all the controls were hospitalized. |
T7 |
989-1238 |
Sentence |
denotes |
Patients with glomerulonephritis had significantly higher mortality (15% vs. 5%, respectively) and acute kidney injury (39% vs. 14%) than controls, while the need for kidney replacement therapy was not statistically different between the two groups. |
T7 |
989-1238 |
Sentence |
denotes |
Patients with glomerulonephritis had significantly higher mortality (15% vs. 5%, respectively) and acute kidney injury (39% vs. 14%) than controls, while the need for kidney replacement therapy was not statistically different between the two groups. |
T8 |
1239-1425 |
Sentence |
denotes |
Receiving immunosuppression or renin-angiotensin-aldosterone system inhibitors at presentation did not increase the risk of death or acute kidney injury in the glomerulonephritis cohort. |
T8 |
1239-1425 |
Sentence |
denotes |
Receiving immunosuppression or renin-angiotensin-aldosterone system inhibitors at presentation did not increase the risk of death or acute kidney injury in the glomerulonephritis cohort. |
T9 |
1426-1641 |
Sentence |
denotes |
In the cohort with glomerulonephritis, lower serum albumin at presentation and shorter duration of glomerular disease were associated with greater risk of acute kidney injury and need for kidney replacement therapy. |
T9 |
1426-1641 |
Sentence |
denotes |
In the cohort with glomerulonephritis, lower serum albumin at presentation and shorter duration of glomerular disease were associated with greater risk of acute kidney injury and need for kidney replacement therapy. |
T10 |
1642-1821 |
Sentence |
denotes |
No differences in outcomes occurred between patients with primary glomerulonephritis versus glomerulonephritis associated with a systemic autoimmune disease (lupus or vasculitis). |
T10 |
1642-1821 |
Sentence |
denotes |
No differences in outcomes occurred between patients with primary glomerulonephritis versus glomerulonephritis associated with a systemic autoimmune disease (lupus or vasculitis). |
T11 |
1822-2083 |
Sentence |
denotes |
Thus, due to the higher mortality and risk of acute kidney injury than in the general population without glomerulonephritis, patients with glomerulonephritis and COVID-19 should be carefully monitored, especially when they present with low serum albumin levels. |
T11 |
1822-2083 |
Sentence |
denotes |
Thus, due to the higher mortality and risk of acute kidney injury than in the general population without glomerulonephritis, patients with glomerulonephritis and COVID-19 should be carefully monitored, especially when they present with low serum albumin levels. |